Oxaliplatin-based adjuvant chemotherapy duration (3 versus 6 months) for high-risk stage II colon cancer: the randomized phase III ACHIEVE-2 trial-Reference-Cited by-同舟云学术

Oxaliplatin-based adjuvant chemotherapy duration (3 versus 6 months) for high-risk stage II colon cancer: the randomized phase III ACHIEVE-2 trial

Published:2021-01 Issue:1 Volume:32 Page:77-84
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Yamazaki K.,Yamanaka T.,Shiozawa M.,Manaka D.,Kotaka M.,Gamoh M.,Shiomi A.,Makiyama A.,Munemoto Y.,Rikiyama T.,Fukunaga M.,Ueki T.,Shitara K.,Shinkai H.,Tanida N.,Oki E.,Sunami E.,Ohtsu A.,Maehara Y.,Yoshino T.

Funder

Yakult Honsha

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference19 articles.

1. Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Labianca;Ann Oncol,2013

2. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer;Hashiguchi;Int J Clin Oncol,2020

3. Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials;Sargent;J Clin Oncol,2009

4. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study;Quasar Collaborative;Lancet,2007

5. Who to treat with adjuvant therapy in Dukes B/stage II colorectal cancer? The need for high quality pathology;Morris;Gut,2007

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel drug delivery systems in colorectal cancer: Advances and future prospects;Pathology - Research and Practice;2024-10

2. Assessment of the Addition of Oxaliplatin to Fluoropyrimidine-Based Adjuvant Chemotherapy in Patients With High-Risk Stage II Colon Cancer: An ACCENT Pooled Analysis;Journal of Clinical Oncology;2024-09-04

3. Essential updates 2022–2023: Surgical and adjuvant therapies for locally advanced colorectal cancer;Annals of Gastroenterological Surgery;2024-08-19

4. Prognostic implications of tumor mutation burden in postoperative patients with colorectal cancer who received capecitabine-based adjuvant chemotherapy: a retrospective exploratory study;2024-05-10

5. Principles of risk assessment in colon cancer: immunity is key;OncoImmunology;2024-04-30